Abstract:Objectives: Epilepsy and migraine are common chronic neurological disease. Epidemiologic studies and shared pathophysiology and treatment suggest that these two diseases overlap. However, migraine is often underestimated among patients with epilepsy. This study aimed to evaluate the prevalence of migraine and identify the related influencing factors among adult patients with epilepsy. Methods: Adult patients with epilepsy were recruited at the outpatient epilepsy clinic of 13 tertiary hospitals in China from February to September 2022. ID Migraine questionnaire was applied to evaluate for migraine. Both univariable and multivariable logistic regression models were used to explore the influencing factors of migraine. Results: A total of 1326 patients with epilepsy were enrolled in this study. The prevalence of migraine among patients with epilepsy was 19.2% (254/1326). In the multivariable analysis, being female (OR = 1.451, 95% CI: 1.068-1.975; p = 0.018), focal and focal to bilateral tonic-clonic seizures (OR = 1.583, 95% CI: 1.090-2.281; p = 0.015), and current seizure attack in the last 3 months (OR = 1.967, 95% CI: 1.282-3.063; p = 0.002) were the influencing factors for migraine. However, <10% of patients with epilepsy received analgesics for migraine. Significance: Approximately 20% of patients with epilepsy screened positive for migraine. Being female, focal and focal to bilateral tonic-clonic seizures, and current seizure attack in the last 3 months were the influencing factors for migraine. Neurologists should pay more attention to the screening and management of the migraine among patients with epilepsy in China. Plain Language Summary: Epilepsy and migraine are common chronic neurological disease with shared pathophysiological mechanisms and therapeutic options. However, migraine is often underestimated among patients with epilepsy. This multicenter study aimed to evaluate the prevalence of migraine and current status of treatment. In this study, approximately 20% of patients with epilepsy screened positive for migraine. Female, focal and focal to bilateral tonic-clonic seizures, and current seizure attack in the last 3 months were identified as independent influencing factors for migraine. Despite the high prevalence, the treatment for migraine was not optimistic, neurologists should pay more attention to the screening and management of migraine.

Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities

Migraine: epidemiology and systems of care

Reviewing migraine-associated pathophysiology and its impact on elevated stroke risk

Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment

Migraine-associated risks and comorbidity

Comorbidities of migraine

Hallmarks of primary headache: part 1 – migraine

Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine

Migraine: Advances in the Pathogenesis and Treatment

Migraine and Diet

Depression comorbidity in migraine

Migraine: Multiple Processes, Complex Pathophysiology

Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives

A Cross‐sectional, Multicenter Survey of the Prevalence and Influencing Factors for Migraine in Epilepsy

Migraine update. Diagnosis and treatment

Understanding the Biological Relationship between Migraine and Depression

Migraine and the correlation between stroke: A systematic review and meta-analysis

Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

Global epidemiology of migraine and its implications for public health and health policy

Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents

Migraine Comorbidities